Luke Sergott
Stock Analyst at Barclays
(2.04)
# 2,850
Out of 4,851 analysts
278
Total ratings
38.33%
Success rate
-6.1%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTRE Fortrea Holdings | Maintains: Underweight | $6 → $5 | $5.00 | +0.10% | 10 | May 13, 2025 | |
| NTRA Natera | Maintains: Overweight | $160 → $190 | $166.62 | +14.03% | 3 | May 9, 2025 | |
| CERT Certara | Upgrades: Overweight | $11 → $14 | $11.98 | +16.86% | 17 | May 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $145 → $155 | $143.90 | +7.71% | 6 | May 8, 2025 | |
| BRKR Bruker | Maintains: Overweight | $50 → $46 | $38.36 | +19.92% | 4 | May 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Equal-Weight | $170 → $165 | $148.23 | +11.31% | 22 | May 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Equal-Weight | $165 → $155 | $139.36 | +11.23% | 19 | May 2, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $55 → $75 | $55.49 | +35.16% | 4 | May 2, 2025 | |
| GH Guardant Health | Maintains: Overweight | $55 → $60 | $46.93 | +27.85% | 3 | May 1, 2025 | |
| AVTR Avantor | Maintains: Overweight | $18 → $15 | $13.57 | +10.54% | 24 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $205 → $215 | $194.84 | +10.35% | 39 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $353.77 | -1.07% | 18 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $45 | $30.57 | +47.20% | 17 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $620 → $475 | $405.45 | +17.15% | 24 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $12 | $12.47 | -3.77% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $110 | $92.76 | +18.59% | 9 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $77 | $83.51 | -7.80% | 17 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $138 → $115 | $114.47 | +0.46% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $12 | $9.38 | +27.93% | 11 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $3 → $2 | $1.03 | +94.17% | 4 | May 10, 2024 |
Fortrea Holdings
May 13, 2025
Maintains: Underweight
Price Target: $6 → $5
Current: $5.00
Upside: +0.10%
Natera
May 9, 2025
Maintains: Overweight
Price Target: $160 → $190
Current: $166.62
Upside: +14.03%
Certara
May 8, 2025
Upgrades: Overweight
Price Target: $11 → $14
Current: $11.98
Upside: +16.86%
Charles River Laboratories International
May 8, 2025
Maintains: Equal-Weight
Price Target: $145 → $155
Current: $143.90
Upside: +7.71%
Bruker
May 8, 2025
Maintains: Overweight
Price Target: $50 → $46
Current: $38.36
Upside: +19.92%
IQVIA Holdings
May 7, 2025
Maintains: Equal-Weight
Price Target: $170 → $165
Current: $148.23
Upside: +11.31%
ICON Public Limited Company
May 2, 2025
Maintains: Equal-Weight
Price Target: $165 → $155
Current: $139.36
Upside: +11.23%
Exact Sciences
May 2, 2025
Maintains: Overweight
Price Target: $55 → $75
Current: $55.49
Upside: +35.16%
Guardant Health
May 1, 2025
Maintains: Overweight
Price Target: $55 → $60
Current: $46.93
Upside: +27.85%
Avantor
Apr 28, 2025
Maintains: Overweight
Price Target: $18 → $15
Current: $13.57
Upside: +10.54%
Apr 22, 2025
Maintains: Overweight
Price Target: $205 → $215
Current: $194.84
Upside: +10.35%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $353.77
Upside: -1.07%
Apr 10, 2025
Maintains: Overweight
Price Target: $58 → $45
Current: $30.57
Upside: +47.20%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $620 → $475
Current: $405.45
Upside: +17.15%
Apr 10, 2025
Maintains: Overweight
Price Target: $16 → $12
Current: $12.47
Upside: -3.77%
Apr 10, 2025
Maintains: Overweight
Price Target: $140 → $110
Current: $92.76
Upside: +18.59%
Apr 10, 2025
Maintains: Underweight
Price Target: $100 → $77
Current: $83.51
Upside: -7.80%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $138 → $115
Current: $114.47
Upside: +0.46%
Apr 10, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $9.38
Upside: +27.93%
May 10, 2024
Maintains: Equal-Weight
Price Target: $3 → $2
Current: $1.03
Upside: +94.17%